Join Growin Stock Community!

Stryker corporationSYK.US Overview

US StockHealthcare
(No presentation for SYK)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

SYK AI Insights

SYK Overall Performance

SYK AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

SYK Recent Performance

-0.28%

Stryker corporation

0.05%

Avg of Sector

-0.31%

S&P500

SYK PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

SYK Key Information

SYK Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

SYK Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Price of SYK

SYK Related Articles

機器人概念股全解析!AI 自動化浪潮下的巨大機會
Oct 01, 2025Industry

機器人概念股全解析!AI 自動化浪潮下的巨大機會

隨著 AI 與自動化技術的快速發展,機器人產業正迎來前所未有的成長契機,機器人概念股涵蓋了從硬體、軟體、機器視覺到自動化系統等核心技術供應商,以及工業自動化、醫療機器人、物流自動化等多元應用領域的公司。

SYK FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

SYK Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
8.48
PE Ratio (TTM)
46.07
Forward PE
25.93
PS Ratio (TTM)
5.90
PB Ratio
6.59
Price-to-FCF
34.58
METRIC
VALUE
vs. INDUSTRY
Gross Margin
63.96%
Net Margin
12.92%
Revenue Growth (YoY)
11.16%
Profit Growth (YoY)
11.25%
3-Year Revenue Growth
11.29%
3-Year Profit Growth
12.67%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
8.48
PE Ratio (TTM)
46.07
Forward PE
25.93
PS Ratio (TTM)
5.90
PB Ratio
6.59
Price-to-FCF
34.58
Gross Margin
63.96%
Net Margin
12.92%
Revenue Growth (YoY)
11.16%
Profit Growth (YoY)
11.25%
3-Year Revenue Growth
11.29%
3-Year Profit Growth
12.67%
  • When is SYK's latest earnings report released?

    The most recent financial report for Stryker corporation (SYK) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating SYK's short-term business performance and financial health. For the latest updates on SYK's earnings releases, visit this page regularly.

  • Where does SYK fall in the P/E River chart?

    According to historical valuation range analysis, Stryker corporation (SYK)'s current price-to-earnings (P/E) ratio is 42.88, placing it in the Reasonable zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of SYK?

    According to the latest financial report, Stryker corporation (SYK) reported an Operating Profit of 1.8B with an Operating Margin of 25.16% this period, representing a growth of 210.5% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is SYK's revenue growth?

    In the latest financial report, Stryker corporation (SYK) announced revenue of 7.17B, with a Year-Over-Year growth rate of 11.42%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does SYK have?

    As of the end of the reporting period, Stryker corporation (SYK) had total debt of 15.86B, with a debt ratio of 0.33. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does SYK have?

    At the end of the period, Stryker corporation (SYK) held Total Cash and Cash Equivalents of 4.01B, accounting for 0.08 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does SYK go with three margins increasing?

    In the latest report, Stryker corporation (SYK) achieved the “three margins increasing” benchmark, with a gross margin of 64.5%%, operating margin of 25.16%%, and net margin of 11.8%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess SYK's profit trajectory and future growth potential.

  • Is SYK's EPS continuing to grow?

    According to the past four quarterly reports, Stryker corporation (SYK)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 2.22. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of SYK?

    Stryker corporation (SYK)'s Free Cash Flow (FCF) for the period is 1.88B, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 12.61% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of SYK?

    The latest valuation data shows Stryker corporation (SYK) has a Price-To-Earnings (PE) ratio of 42.88 and a Price/Earnings-To-Growth (PEG) ratio of -22.27. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.